Regeneron Pharmaceuticals has come out with a drug known as IL-1 Trap which can be effectively used for treatment of CAPS or CIAS1-related autoinflammatory periodic syndromes. It is regarded as a rare inherited spectrum of inflammatory conditions and the symptoms of this disease are spontaneous systemic inflammation. People suffering from this disease get the inflammation when they get exposed to cold temperatures. Regeneron is looking forward to get the approval from FDA in the second quarter of 2007 after the open label extension study is completed. Already the drug has got orphan drug status and this status is granted in case of only those drugs which are being developed for treating rare diseases.
- Regeneron Develops Drug for Treatment of CAPS
- GM Rice Field Trials Don’t Impress Indian Rice Traders
- Would You Like To Taste GM Wine?
- Field Trials of GM Cabbage Could Lead To Increased Resistance among Pests
- Indian Government In Favor Of GM Seeds
- Indian Prime Minister States Country Needs to Balance GM Fear with Food Security
- A Ray of Hope for Type I Diabetes Patient
- Anthrax Vaccine Trial Faces a Setback
- Make Case for Biotechnology, Says Tony Blair
- Promising Solution Found In Gene Therapy Delivery